Search

Author/Creator Couteau C. investigator.

1. Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized multicentre trial. (10th March 2021)

Authors:
Karoui, Mehdi; Gallois, Claire; Piessen, Guillaume; Legoux, Jean‐Louis; Barbier, Emilie; De Chaisemartin, Cecile; Lecaille, Cedric; Bouche, Olivier; Ammarguellat, Hanifa; Brunetti, Francesco; Prudhomme, Michel; Regimbeau, Jean‐Marc; Glehen, Olivier; Lievre, Astrid; Portier, Guillaume; Hartwig, Jo...
Other Names:
Ainseba N. investigator.; Alcaraz L. investigator.; Audemar F. investigator.; Bachet J. B. investigator.; Bardier A. investigator.; Baumgaertner I. investigator.; Luciani A. investigator.; Bège T. investigator.; Ben Abdelghani M. investigator.; Bourgeois V. investigator.; Brigand C. investigator....
Journal:
Colorectal disease
Issue:
Volume 23:Number 6(2021)
Page Start:
1357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search